Ticker

Analyst Price Targets — KMDA

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
March 11, 2026 3:01 pmAnnabel SamimyStifel Nicolaus$11.00$8.55StreetInsider Stifel Reiterates Buy Rating on Kamada Ltd. (KMDA)
December 9, 2025 11:11 amH.C. Wainwright$13.00$6.73TheFly Kamada price target raised to $13 from $11 at H.C. Wainwright
November 13, 2024 4:05 pmAnnabel SamimyStifel Nicolaus$20.00$6.03StreetInsider Kamada Ltd. (KMDA) PT Raised to $20 at Stifel

Latest News for KMDA

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated with improved clinical outcomes, supporting increased CYTOGAM utilization Findings from analyses of CMV high-risk lung transplant recipients suggest CYTOGAM use is associated with improved clinical outcomes, supporting increased CYTOGAM utilization

GlobeNewsWire • Jul 13, 2026
Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory

REHOVOT, Israel and HOBOKEN, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived therapies field, today announced FDA approval of the Company's new in-house Rapid Fluorescent Focus Inhibition Test (RFFIT) laboratory. RFFIT is…

GlobeNewsWire • Jun 1, 2026
Kamada Q1 Earnings Call Highlights

Kamada NASDAQ: KMDA reiterated its full-year 2026 outlook after reporting first-quarter results that management said were in line with expectations, excluding a temporary shipment delay that shifted revenue into April.

MarketBeat • May 13, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for KMDA.

No House trades found for KMDA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top